Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Beeline Eliminates $7 Million in Debt, Positioned for Cash Flow Positive Operations by Q1 2026
-
Inuvo to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8th-10th
-
Mandragora: Whispers of the Witch Tree Now Available on PlayStation®5 and Nintendo Switch in Asia
-
BiomX CEO to Present at H.C. Wainwright 27th Annual Global Investment Conference
-
SDHG H1 2025 Profit Soars 506 Percent, Riding Green Energy and Computing Boom
-
Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
-
STRATA Skin Sciences’ Elevate 360 Consulting Offering Drives Growth in Partner Clinic Operations and Fuels New Partnership Agreements
-
ZenaTech to Highlight Progress on Drone as a Service and US Defense Business at Multiple Upcoming Investor Conferences
-
All Marketing Leaders Say Their Employees Have Embraced AI for Their Marketing and Advertising Work; 25% Have Used it to Replace Humans
-
Hitachi announces historic $1 billion USD manufacturing investment to power America’s energy future through production of critical grid infrastructure
-
24/7 Market News: TEN Holdings Poised for High-Growth with SaaS Expansion and M&A Potential, Says All-Star
-
Sangamo Therapeutics Presents Detailed Data from Registrational STAAR Study in Fabry Disease at International Congress of Inborn Errors of Metabolism 2025
-
IO Biotech Announces Participation in Upcoming Investor Conferences
-
24/7 Market News: TEN Holdings Poised for High-Growth with SaaS Expansion and M&A Potential, Says All-Star
-
Stellantis CEO Antonio Filosa to Participate in Kepler Cheuvreux Autumn Conference 2025
-
Xeriant Successfully Completes August Production Run of NEXBOARD Panels
-
Stellantis CEO Antonio Filosa to Participate in Kepler Cheuvreux Autumn Conference 2025
-
Kids Help Phone to Create the First National Youth Mental Health Foundation in Canada
-
Sharp introduces the MultiSync® PN-E Series Displays. Essential performance. Ideal for Education, Corporate and Digital Signage Applications
-
RebelsFunding one of the Top-rated Prop Firms Announces Discounts up to 55% on selected Programs
-
MBX Biosciences Doses First Participant in Phase 1 Trial of MBX 4291 for the Treatment of Obesity
-
Tharimmune Announces Upcoming Conference Presentations Highlighting Lead Asset TH104, A New Formulation Against Ultrapotent Opioids and Fentanyl
-
StoneX Acquires Right Corp, Expanding Global Trading Capabilities to Include Wholesale Meat Supply and Distribution
-
Cerence AI and SiMa.ai Partner to Power Next-Gen Conversational AI at the Edge
-
POET Technologies to Showcase Breakthrough Light Source and 1.6T Optical Engines for AI and Cloud Markets at CIOE 2025
-
ORYZON Finalist at the 2025 European Lifestars Awards
-
Grace Therapeutics Announces Presentation at The H.C. Wainwright 27th Annual Global Investment Conference
-
electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief
-
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Robert Thast, CEO of Izotropic Corp.
-
Elutia Selected to Exhibit EluPro™ Antibiotic Eluting BioEnvelope at Vizient Innovative Technology Exchange
-
Greenbacker names Daniel de Boer as CEO and Carl Weatherley-White as CFO, further solidifying the team leading Greenbacker through its next phase of growth and profitability
-
PathAI Expands Clinical Leadership - Announcing Partnerships with Mindpeak, Stratipath, and Primaa
-
Gauzy Ltd. to Attend B. Riley Securities Consumer & TMT Conference
-
Terra Innovatum Announces Post-Closing Board of Directors and Nominates Former Framatome CEO Katherine Williams as Chair
-
Ashvattha Therapeutics Announces Positive Topline 40-Week Phase 2 Results for Migaldendranib in Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
-
Bluejay Therapeutics Enrolls First Patient in AZURE-2 Global Phase 3 Clinical Trial Evaluating Brelovitug (BJT-778) Compared to Hepcludex® (Bulevirtide) for Chronic Hepatitis D
-
Aventis Energy Announces VTEM Survey on the Sting Copper Project
-
Opus Genetics Doses First Patient in Pivotal LYNX-3 Phase 3 Trial Evaluating Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Co
-
Marquis Auto: Brooklyn Car Lease Broker Adds $0 Down Payment to Suite of Unbeatable Deals Across New York
-
Top KingWin Ltd Announces 1-For-25 Reverse Share Split
-
Roadzen Inc. Announces Strategic Equity Financing of Approximately $4.5 Million for Its India Subsidiary at an $84 Million Pre-Money Valuation
-
Beyond Oil Announces Exclusive Distribution Agreements in Four European Countries with Pilpel Hungary Kft.
-
Valitor Presents New Preclinical Data Demonstrating VLTR-559, an Anti-VEGF Drug Candidate for Wet AMD with a Twice-Yearly “Treat-and-Release” Regimen, Exhibits Favorable Safety Profile Similar to
-
Kane Biotech to Present revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Fall Conference
-
Stran & Company to Present at the H.C. Wainwright 27th Annual Global Investment Conference
-
Beacon Therapeutics Announces Positive Interim 9+ Month Results from DAWN Trial and 36-Month Phase 2 SKYLINE Trial Data for Laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at EURETINA
-
Cidara Therapeutics to Participate in September Investor Conferences
-
Terra Innovatum Announces Post-Closing Board of Directors and Nominates Former Framatome CEO Katherine Williams as Chair
-
Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation
-
GraniteShares Announces Weekly Distributions for its YieldBOOST ETFs: COYY, TSYY, NVYY, XBTY, TQQY and YSPY
